McKesson Corp. closed 6.64% below its 52-week high of $637.51, which the company achieved on August 2nd.

The S&P 500’s health care sector (NYSEARCA:XLV), holding a weightage of 12.12% in the S&P 500 index, saw a fall of 10.2% in ...

AdvisorNet Financial Inc lessened its holdings in McKesson Co. (NYSE:MCK – Free Report) by 11.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional ...

The stock's fall snapped a two-day winning streak.

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

McKesson (MCK) concluded the recent trading session at $585.08, signifying a +0.57% move from its prior day's close.

Park Avenue Securities LLC lessened its position in McKesson Co. (NYSE:MCK – Free Report) by 2.5% during the fourth quarter, according to the company in its most recent filing with the Securities & ...

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The transaction enables McKesson to focus capital deployment and prioritize investments in strategic oncology and biopharma ...

Citi lowered the firm’s price target on McKesson (MCK) to $677 from $713 and keeps a Buy rating on the shares as part of a 2025 outcook for the ...